quality of care

Research in Review

Transplantation After High-Dose Chemo Effective in Treating Multiple Myeloma

04/19/2017

JCP Editors

Adult patients with multiple myeloma who receive a high-dose chemotherapy regimen plus autologous stem-cell transplantation improve their median progression-free survival (PFS) by 14 months compared with patients who...

Adult...

04/19/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy After Autologous Stem Cell Transplant Improves Survival in MCL

04/18/2017

JCP Editors

Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...

...

04/18/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy Effective in Treating Diffuse Large B-Cell Lymphoma

04/12/2017

JCP Editors

Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One...

...

04/12/2017

Journal of Clinical Pathways

Department

Implementing Clinical Pathways for Multiple Myeloma

04/12/2017

JCP Editors

Multiple myeloma represents a key area for clinical pathway development. In one survey of payers, 47.6% reported having pathways for multiple myeloma, with another 19.1% citing the cancer type as a high priority for...

...

04/12/2017

Journal of Clinical Pathways

Research in Review

Leukemia Survival Outcomes Differ Between Sites of Care

04/11/2017

JCP Editors

Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...

Sites...

04/11/2017

Journal of Clinical Pathways

Editor's Page

Clinical Pathways and Access to Quality Care

04/11/2017

Winston Wong, PharmD, Editor-in-Chief

Patients are entitled to the best possible health care at the lowest possible cost. Clinical pathways have served to promote evidence-based medicine and value-based care across the medical continuum. The quality of...

...

04/11/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy for MCL Improved by Targeted Drugs

04/10/2017

JCP Editors

Recent advances in targeted therapies have the potential for major impacts on treatment practices for mantle cell lymphoma (MCL), according to a recent review published in Pharmaceuticals...

Recent...

04/10/2017

Journal of Clinical Pathways

Research in Review

Rare Form of Colorectal Cancer Responds Well to Precision Medicine

04/06/2017

JCP Editors

Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...

...

04/06/2017

Journal of Clinical Pathways

Research in Review

Immune Systems Impact Immunotherapy Effectiveness in Head and Neck Cancer

04/05/2017

JCP Editors

Specific immune cells surrounding tumors may play a crucial role in how patients with head and neck cancer respond to nivolumab immunotherapy, according to research presented at the American Association of Cancer...

...

04/05/2017

Journal of Clinical Pathways

Research in Review

Kidney Cancer Pulmonary Metastases May Hide Primary Lung Cancer Diagnosis

03/27/2017

JCP Editors

Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research. ----- Related Content Leptomeningeal Metastases More Common in EGFR+...

...

03/27/2017

Journal of Clinical Pathways